Matthew Moore
Chief Operating Officer at VENTYX BIOSCIENCES, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Matthew Moore is currently the Chief Operating Officer at Ventyx Biosciences, Inc. He previously held the position of Vice President-Corporate Business Development at Allergan Ltd.
(Ireland) from 2015 to 2020.
Prior to that, he served as the Chief Business Officer & Senior Vice President at Arcutis Biotherapeutics, Inc. from 2021 to 2024.
Mr. Moore completed his undergraduate degree at Trinity College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-01 | 145,505 ( 0.13% ) | 1 M $ | 2024-04-29 | |
VENTYX BIOSCIENCES, INC.
-.--% | 2024-05-15 | 0 ( -.--% ) | - $ | 2024-04-29 |
Matthew Moore active positions
| Companies | Position | Start |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Chief Operating Officer | 2024-05-15 |
Former positions of Matthew Moore
| Companies | Position | End |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 2024-04-30 |
| ALLERGAN PLC | Corporate Officer/Principal | 2019-12-31 |
Training of Matthew Moore
| Trinity College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Matthew Moore
